NTT Biopharma has its own pipeline of  nano-formulation of NCE/505(b)(2) products, we focusing on solving the problem faced by NCE and genetic drugs such as poor solubility, insufficient bioavailability, unwanted toxicity, etc. to provide new formulations or drug repurposing opportunities to add value to the original products.